Optimal treatment strategy using appropriate use criteria

    Authors

    Abstract

    Introduction: Coronary atherosclerotic heart disease is the leading cause of death worldwide. The clinical presentation of the disease is extremely variable – from mild chronic and asymptomatic disease to acute and life threatening. The appropriate use criteria (AUC) for coronary revascularization is a new tool to help cardiologists with clinical decision making. (1) The criteria are based on the clinical presentation, severity of symptoms, extent of ischemia on non-invasive testing, risk assessment, use of anti-ischemic therapy and coronary anatomy. The Technical panel scored the clinical scenarios on a scale 1-9. Scores of 7-9 indicate that revascularization is appropriate, while scores 1-3 indicate inappropriate revascularization. Patients and Methods: We analyzed 20 patients who have undergone coronary angiography and PCI. 10 patients were with stable coronary artery disease and 10 were acute coronary syndrome patients. In decision making we used SCAI Quality Improvement Toolkit. In a group of stabile coronary artery disease we found 7 patients to be appropriate to revascularize. Among them we performed ad hoc PCI on 3 patients, staged PCI on 3 patients, 1 patient was referred for CABG, while 3 patients were uncertain for revascularization and we put them on optimal medical therapy. In a group of ACS patients all 10 patients were appropriate for revascularization, in 7 patients we performed ad hoc PCI, in 2 patients we did staged PCI, while 1 patient was referred to CABG. Conclusion: The appropriate use criteria (AUC) for coronary revascularization is a tool to help cardiologists, not a threat. As a general rule, patients with ACS are usually appropriate for cardiac catheterization and PCI, while asymptomatic patients, particularly those without noninvasive testing are inappropriate. The main issue of AUC is to question your own judgment and improve your current practice.

    Keywords

    coronary revascularization, acute coronary syndrome, stable coronary disease

    DOI

    https://doi.org/10.15836/ccar.2015.234

    Literature

    1. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2012;59(9):857–81. https://doi.org/10.1016/j.jacc.2011.12.001
    Cardiologia Croatica
    Back to search

    Optimal treatment strategy using appropriate use criteria

    Abstract
    Issue9-10
    Published
    Pages234
    PDF via DOIhttps://doi.org/10.15836/ccar.2015.234
    coronary revascularization
    acute coronary syndrome
    stable coronary disease

    Authors

    Krešimir GabaldoORCIDGeneral Hospital “Dr. Josip Bencevic”, Slavonski Brod, Croatia
    Deiti PrvulovicORCIDGeneral Hospital “Dr. Josip Bencevic”, Slavonski Brod, Croatia
    Bozo VujevaORCIDGeneral Hospital “Dr. Josip Bencevic”, Slavonski Brod, Croatia
    Irzal HadzibegovicORCIDGeneral Hospital “Dr. Josip Bencevic”, Slavonski Brod, Croatia

    Abstract

    Introduction: Coronary atherosclerotic heart disease is the leading cause of death worldwide. The clinical presentation of the disease is extremely variable – from mild chronic and asymptomatic disease to acute and life threatening. The appropriate use criteria (AUC) for coronary revascularization is a new tool to help cardiologists with clinical decision making. (1) The criteria are based on the clinical presentation, severity of symptoms, extent of ischemia on non-invasive testing, risk assessment, use of anti-ischemic therapy and coronary anatomy. The Technical panel scored the clinical scenarios on a scale 1-9. Scores of 7-9 indicate that revascularization is appropriate, while scores 1-3 indicate inappropriate revascularization. Patients and Methods: We analyzed 20 patients who have undergone coronary angiography and PCI. 10 patients were with stable coronary artery disease and 10 were acute coronary syndrome patients. In decision making we used SCAI Quality Improvement Toolkit. In a group of stabile coronary artery disease we found 7 patients to be appropriate to revascularize. Among them we performed ad hoc PCI on 3 patients, staged PCI on 3 patients, 1 patient was referred for CABG, while 3 patients were uncertain for revascularization and we put them on optimal medical therapy. In a group of ACS patients all 10 patients were appropriate for revascularization, in 7 patients we performed ad hoc PCI, in 2 patients we did staged PCI, while 1 patient was referred to CABG. Conclusion: The appropriate use criteria (AUC) for coronary revascularization is a tool to help cardiologists, not a threat. As a general rule, patients with ACS are usually appropriate for cardiac catheterization and PCI, while asymptomatic patients, particularly those without noninvasive testing are inappropriate. The main issue of AUC is to question your own judgment and improve your current practice.

    Literature

    1. 1.
      Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2012;59(9):857–81.DOI